VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017Management of end-stage liver disease in HIV patients | Ana Morbey, MDView Video
VSVincent SorianoMD, PhDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017News on hepatitis delta and HIV infections | Vincent Soriano, MD, PhDView Video
KSKenneth ShermanMD, PhDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017Hepatitis E in HIV | Kenneth Sherman, MD, PhDView Video
RSeCRui Sarmento e CastroMD, PhDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017Management of HCV in intravenous drug users: special considerations | Rui Sarmento e Castro, MD, PhDView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2018Session 1 Panel discussionView Video
TBThomas BergMDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2018Stopping Nucleos(t)ide Analogues: When is it beneficial, when is it dangerous? | Thomas Berg, MDView Video
AGAdam GehringPhDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2018Will HBsAg depletion restore HBV specific immunity? | Adam Gehring, PhDView Video
JFJordan FeldMD, MPHVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2018What are the pros and cons of HBsAg loss as the endpoint for treatment? | Jordan Feld, MD, MPHView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2018Session 2 Panel discussionView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2018Anti-HBV potential of PD-1/PD-L1 blockade in chronic HBV infection | Daniel VerdonView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2018Innate activation with Inactivated parapox viruses for HBV therapy - AIC649 | Daniela PaulsenView Video
MMMala MainiMD, PhDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2018Rationale for modulating innate immunity: TLR, RIG- and others | Mala Maini, MD, PhDView Video
